share_log

United Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer MAHON PAUL A

United Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer MAHON PAUL A

美國聯合醫療 | 4：持股變動聲明-高管 MAHON PAUL A
美股SEC公告 ·  2024/12/21 05:36

牛牛AI助理已提取核心訊息

Paul A. Mahon, EVP & General Counsel of United Therapeutics, executed a stock transaction on 12/19/2024. Mahon exercised 7,700 shares of Common Stock at $163.30 per share through a derivative security conversion, immediately followed by a sale of the same number of shares at $360.16 each.The total value of the disposed shares amounted to $2,773,232. After these transactions, Mahon's direct ownership in United Therapeutics decreased to 36,710 shares. The transactions were completed on the same day, indicating a planned exercise-and-sell strategy.This insider activity provides insight into executive stock operations at United Therapeutics, potentially reflecting the company's stock-based compensation practices and the executive's personal financial management decisions.
Paul A. Mahon, EVP & General Counsel of United Therapeutics, executed a stock transaction on 12/19/2024. Mahon exercised 7,700 shares of Common Stock at $163.30 per share through a derivative security conversion, immediately followed by a sale of the same number of shares at $360.16 each.The total value of the disposed shares amounted to $2,773,232. After these transactions, Mahon's direct ownership in United Therapeutics decreased to 36,710 shares. The transactions were completed on the same day, indicating a planned exercise-and-sell strategy.This insider activity provides insight into executive stock operations at United Therapeutics, potentially reflecting the company's stock-based compensation practices and the executive's personal financial management decisions.
保羅·A·馬洪，美國聯合醫療的執行副總裁兼總法律顧問，於2024年12月19日進行了股票交易。馬洪通過衍生證券轉換行使了7,700股普通股，每股價格爲163.30美元，緊接着以每股360.16美元的價格出售了相同數量的股票。處置股票的總價值達到了2,773,232美元。完成這些交易後，馬洪在美國聯合醫療的直接持股減少至36,710股。這些交易在同一天完成，表明了一個計劃好的行使和賣出策略。這一內部活動提供了對美國聯合醫療高管股票操作的見解，可能反映了公司基於股票的薪酬實踐以及高管的個人財務管理決策。
保羅·A·馬洪，美國聯合醫療的執行副總裁兼總法律顧問，於2024年12月19日進行了股票交易。馬洪通過衍生證券轉換行使了7,700股普通股，每股價格爲163.30美元，緊接着以每股360.16美元的價格出售了相同數量的股票。處置股票的總價值達到了2,773,232美元。完成這些交易後，馬洪在美國聯合醫療的直接持股減少至36,710股。這些交易在同一天完成，表明了一個計劃好的行使和賣出策略。這一內部活動提供了對美國聯合醫療高管股票操作的見解，可能反映了公司基於股票的薪酬實踐以及高管的個人財務管理決策。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    熱議
    美股
    股票代碼最新價升跌幅

    暫無數據

    資訊熱榜
    更新時間